SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+11.02%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$185M
AUM Growth
+$185M
(+42%)
Cap. Flow
+$51M
Cap. Flow
% of AUM
27.54%
Top 10 Holdings %
Top 10 Hldgs %
73.08%
Holding
35
New
14
Increased
11
Reduced
4
Closed
6
Top Buys
| 1 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
$15.4M |
| 2 |
CHMA
Chiasma, Inc. Common Stock
CHMA
|
$13.2M |
| 3 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$12.5M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$10.8M |
| 5 |
Ovid Therapeutics
OVID
|
$9.98M |
Top Sells
| 1 |
Ligand Pharmaceuticals
LGND
|
$32.4M |
| 2 |
AYTU BioPharma
AYTU
|
$7.87M |
| 3 |
SCYNEXIS
SCYX
|
$5.24M |
| 4 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$4.83M |
| 5 |
NEOS
Neos Therapeutics, Inc
NEOS
|
$3.1M |
Sector Composition
| 1 | Healthcare | 88.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMYT
1
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $35.2M | 18.99% | 2,523,728 +1,107,245 | +78% | +$15.4M |
|
|
ADMS
2
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $16.4M | 8.86% | 3,418,279 +2,609,848 | +323% | +$12.5M |
|
|
CHMA
3
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $15.5M | 8.35% | 4,940,273 +4,218,966 | +585% | +$13.2M |
|
4
Gyre Therapeutics
GYRE
$703M
| $12.3M | 6.67% | 2,450,193 +1,615,744 | +194% | +$8.14M |
|
|
5
KalVista Pharmaceuticals
KALV
$678M
| $10.8M | 5.86% | +422,310 | New | +$10.8M |
|
|
6
Ovid Therapeutics
OVID
$91M
| $9.98M | 5.39% | +2,483,059 | New | +$9.98M |
|
|
CTIC
7
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $9.58M | 5.18% | 3,293,419 +1,239,419 | +60% | +$3.61M |
|
8
DiaMedica Therapeutics
DMAC
$295M
| $9.36M | 5.06% | 1,023,409 +73,409 | +8% | +$672K |
|
|
AFMD
9
DELISTED
Affimed
AFMD
| $8.15M | 4.4% | 1,030,004 +810,664 | +370% | +$6.41M |
|
|
APEN
10
DELISTED
Apollo Endosurgery, Inc.
APEN
| $7.98M | 4.31% | 1,448,868 -877,297 | -38% | -$4.83M |
|
11
Xoma
XOMA
$392M
| $6.66M | 3.6% | 163,266 +39,136 | +32% | +$1.6M |
|
|
KA
12
DELISTED
Kineta, Inc. Common Stock
KA
| $6.08M | 3.28% | 335,745 +226,898 | +208% | +$4.11M |
|
|
ISEE
13
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.41M | 2.92% | 875,180 +75,180 | +9% | +$465K |
|
|
PLXP
14
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $4.57M | 2.47% | +506,274 | New | +$4.57M |
|
|
CFMS
15
DELISTED
Conformis, Inc. Common Stock
CFMS
| $4.39M | 2.37% | +4,431,807 | New | +$4.39M |
|
16
EyePoint Pharmaceuticals
EYPT
$797M
| $3.34M | 1.81% | +329,130 | New | +$3.34M |
|
17
Exagen
XGN
$217M
| $3.34M | 1.81% | +191,006 | New | +$3.34M |
|
|
18
AYTU BioPharma
AYTU
$21.1M
| $2.76M | 1.49% | 362,910 -1,035,866 | -74% | -$7.87M |
|
19
Elicio Therapeutics
ELTX
$172M
| $2.44M | 1.32% | +134,984 | New | +$2.44M |
|
|
GMDA
20
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $1.98M | 1.07% | 244,515 -134,955 | -36% | -$1.09M |
|
21
Celcuity
CELC
$2.17B
| $1.56M | 0.84% | +109,081 | New | +$1.56M |
|
|
CFRX
22
DELISTED
ContraFect Corporation
CFRX
| $1.29M | 0.7% | +269,101 | New | +$1.29M |
|
|
SBBP
23
DELISTED
Strongbridge Biopharma plc.
SBBP
| $1.23M | 0.66% | 445,701 -904,299 | -67% | -$2.5M |
|
24
Aptevo Therapeutics
APVO
$5.39M
| $1.18M | 0.64% | 38,593 +20,313 | +111% | +$620K |
|
25
Corvus Pharmaceuticals
CRVS
$428M
| $974K | 0.53% | +316,279 | New | +$974K |
|